Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net Income (Loss)	$ (990,925)	$ (52,992)	$ (203,623)	$ (473,066)
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by (Used in) Operating Activities:
Gain on Forgiveness from PPP Loan				(675,598)
Other Income from Partial Settlement of Debt			(40,346)	(520,221)
Depreciation and Amortization	453,608	435,013	1,348,645	1,286,279
Amortization of Deferred Loan Costs and Debt Discount				157,291
Provision for Bad Debt	252,050	12,142	783,524	28,275
Stock Based Compensation				18,900
Changes in Operating Assets and Liabilities, Net of Assets and Liabilities Acquired:
Accounts and Rents Receivable			(341,724)	(2,535,412)
Prepaid Expenses and Other Assets			616,540	853,451
Accounts Payable and Accrued Liabilities			(2,837,981)	248,337
Lease Security Deposits			24,317	7,000
Cash Used in Operating Activities			(650,648)	(1,604,764)
Cash Flows From Investing Activities:
Capital Expenditures for Property and Equipment			(330,769)	(493,689)
Cash Used in Investing Activities			(330,769)	(493,689)
Cash Flows From Financing Activities:
Proceeds from Issuance of Debt, Non-Related Party				9,134,102
Payments on Debt, Non-Related Party			(1,075,491)	(8,023,719)
Dividends Paid on Preferred Stock			(22,500)	(30,000)
Proceeds from stock offering				713,625
Purchase of Non-Controlling Interest				(60,000)
Debt Discount – Warrants RP			46,466
Cash (Used in) Provided by Financing Activities			(1,051,525)	1,734,008
Net Decrease in Cash, Cash Equivalents and Restricted Cash			(2,032,942)	(364,445)
Cash and Cash Equivalents and Restricted Cash at Beginning of the Period			4,793,101	3,978,303
Cash and Cash Equivalents and Restricted Cash at End of the Period	2,760,159	3,613,858	2,760,159	3,613,858
Supplemental Disclosure of Cash Flow Information
Cash Paid for Interest			1,438,629	1,680,540
Cash	1,928,472	2,791,585	1,928,472	2,791,585
Restricted Cash	831,687	822,273	831,687	822,273
Total Cash and Cash Equivalents and Restricted Cash	$ 2,760,159	$ 3,613,858	2,760,159	3,613,858
Supplemental Schedule of Non-Cash Investing and Financing Activities
Dividends Declared on Series D Preferred Stock			22,500	22,500
Issuance of common stock for cashless exercise of warrants				976
Issuance of common stock for cashless exercise of options				1,560
Financing of Insurance Premiums			$ 581,393	$ 507,433